BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 5, 2015
View Archived Issues
Study of GABA-A receptor signaling in Down syndrome model yields potential treatment strategy
Read More
TaiGen initiates phase I/II trial of burixafor in AML
Read More
Discovery of a bacterial RNR-targeting antibiotic to combat resistance
Read More
Lycera enters clinic with first program, LYC-30937 for IBD
Read More
Advanced Proteome Therapeutics reports findings on APC-191 in tumor metastasis
Read More
Tamir Biotechnology updates development progress of TMR-004 for Ebola
Read More
Novo Nordisk presents pipeline events of first quarter 2015
Read More
AstraZeneca discloses novel PI3Kalpha/delta inhibitior
Read More
BioLineRx's phase II study of BL-8040 for AML enters expansion stage
Read More
Shire and Foundation Fighting Blindness collaborate on autosomal dominant retinitis pigmentosa
Read More
New efficacy data presented for the antibody-drug conjugate ASN-004
Read More
Isis licenses ISIS-FXIRx to Bayer for prevention of thrombosis
Read More
Eisai develops new TLR7 and TLR8 antagonists
Read More
GlaxoSmithKline patents PERK inhibitors
Read More
Dana-Farber Cancer Institute discloses CDK7 inhibitors
Read More
Syros Pharmaceuticals and Paraza Pharma patent CDK7 inhibitors
Read More
The Blanchette Rockefeller Neurosciences Institute patents PKC-epsilon activators
Read More
Generon's F-652 cleared to enter phase II for acute graft-versus-host disease
Read More
Baxter submits European MAA for MM-398 for pancreatic cancer
Read More
European orphan drug designation for Makindus' MI-100 in Stargardt's disease
Read More
Dosing begins in Nigerian bridging study of Lodonal for HIV/AIDS
Read More
New phase II trial investigates Luminate for non-proliferative diabetic retinopathy
Read More
AEOL-10150 doubles survival in primate model of radiation-induced lung injury
Read More
CytRx offers interim reports from phase Ib aldoxorubicin combination studies
Read More
ARVO news: First-in-human clinical study of RetinoStat in wet AMD
Read More